A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
NCT00370513
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
pazopanib
Sponsor
GlaxoSmithKline